Recent research published in Cell demonstrates that facial fibroblasts possess a unique neural crest embryonic origin that allows them to heal wounds with significantly less scarring than fibroblasts from other body parts. This regenerative ability is governed by the SLIT2-ROBO2 signaling pathway, which maintains these cells in a less differentiated, pro-regenerative state. The study reveals that ROBO2 works through the protein EID1 to suppress EP300, a key regulator that otherwise promotes the formation of thick, fibrotic scar tissue. By applying a small-molecule EP300 inhibitor to dorsal wounds, the researchers were able to mimic the low-scarring environment of the face, effectively reducing scar width and promoting hair follicle regeneration. These findings highlight how positional identity and chromatin-level regulation influence tissue repair, offering a potential therapeutic strategy for minimizing permanent scarring in humans.

References:

• Griffin M F, Li D J, Chen K, et al. Fibroblasts of disparate developmental origins harbor anatomically variant scarring potential[J]. Cell, 2026.